b*n
2 楼
想在sears 买个 nikon 24-70, 不知道靠不靠谱。不知哪位前辈有经验,给点意见。
c*o
3 楼
这种被政府调查的,结果未明很凶险。 类似的案例JNJ和AMGN都赔了至少几百M.
b*n
6 楼
多谢提醒, 果真不是sears. 是一个叫 cameta camera的,还是算了吧
x*n
9 楼
一笑而过。
j*9
11 楼
edu很快会跌。
b*n
14 楼
包子就是伪币吧,我查了下0.10可用,怎么发
T*C
22 楼
Orphan Label
"qualify for tax credits for certain clinical testing expenses and for a
seven-year exclusivity period during which the FDA is prohibited from
approving any other ACTH formulation for IS unless the other formulation is
demonstrated to be clinically superior to Acthar or is considered by the FDA
to have an active ingredient that is different from the active ingredient
of Acthar. "
【在 U********f 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: label给的7年测试特权到期-- 这个英文怎么说?
: 我想GOOGLE 一下, 多谢了。
"qualify for tax credits for certain clinical testing expenses and for a
seven-year exclusivity period during which the FDA is prohibited from
approving any other ACTH formulation for IS unless the other formulation is
demonstrated to be clinically superior to Acthar or is considered by the FDA
to have an active ingredient that is different from the active ingredient
of Acthar. "
【在 U********f 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: label给的7年测试特权到期-- 这个英文怎么说?
: 我想GOOGLE 一下, 多谢了。
U*f
23 楼
you are right, I found this:
http://finance.yahoo.com/news/Questcor-Acthar-Drug-Getting-ibd-
it's been off-patent for decades
is
FDA
【在 T*C 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: Orphan Label
: "qualify for tax credits for certain clinical testing expenses and for a
: seven-year exclusivity period during which the FDA is prohibited from
: approving any other ACTH formulation for IS unless the other formulation is
: demonstrated to be clinically superior to Acthar or is considered by the FDA
: to have an active ingredient that is different from the active ingredient
: of Acthar. "
http://finance.yahoo.com/news/Questcor-Acthar-Drug-Getting-ibd-
it's been off-patent for decades
is
FDA
【在 T*C 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: Orphan Label
: "qualify for tax credits for certain clinical testing expenses and for a
: seven-year exclusivity period during which the FDA is prohibited from
: approving any other ACTH formulation for IS unless the other formulation is
: demonstrated to be clinically superior to Acthar or is considered by the FDA
: to have an active ingredient that is different from the active ingredient
: of Acthar. "
n*c
24 楼
到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
跌23%。
Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
http://www.citronresearch.com/2012/07/
跌23%。
Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
http://www.citronresearch.com/2012/07/
U*f
25 楼
NM 这不又是一个MUDDY WATER这类的空头机构,你把它当作神了?
它专门攻击中概股的,看看它对QIHU, 恒大地产
看看这个
http://www.citronresearch.com/citron-knows-china/
也攻击过EDU的,
EDU New Oriental Education 04/16/09 49.50 64.0000 29.29%
Formal SEC Investigation
它专门攻击中概股的,看看它对QIHU, 恒大地产
看看这个
http://www.citronresearch.com/citron-knows-china/
也攻击过EDU的,
EDU New Oriental Education 04/16/09 49.50 64.0000 29.29%
Formal SEC Investigation
U*f
26 楼
PUMP你个头,你作空只管作,SHORT 加PUT ,赚死你。
【在 n****c 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: 到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
: 跌23%。
: Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
: http://www.citronresearch.com/2012/07/
【在 n****c 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: 到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
: 跌23%。
: Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
: http://www.citronresearch.com/2012/07/
T*C
27 楼
太幼稚了。今天已经回到19块了
【在 n****c 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: 到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
: 跌23%。
: Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
: http://www.citronresearch.com/2012/07/
【在 n****c 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: 到现在还有人在pump QCOR. 真的是无语.下面这个是Citron的报告。 出报告的当天大
: 跌23%。
: Questcor (NASDAQ:QCOR): A Single Digit Stock in 18 Months and Here's Why
: http://www.citronresearch.com/2012/07/
U*f
29 楼
我已卖了CALL了,涨多少我都只能赚20%
U*f
32 楼
Take a look at this comment:
if you compare Aetna policy statement in 2008 and 9-12 (recently updated)
there is no change in aetna policy at all. Yes, they might make it more
difficult to approve prior auth. but they are no denying acthar therapy
after steroid therapy fails. The updated policy on 9-14-12 states " This CPB
is revised to state that repository corticotropin is considered not
medically necessary for corticosteroid-responsive conditions because it has
not been proven to be more effective than corticosteroids for these
indications". Now, the keyword here is "corticosteroid-respon... conditions"
which implies acthar gel will not be reimbursed for patients who are
responsive to steroid therapy. However, no where it says it will not
reimburse for patients who failed steroid therapy. This is the language used
by citron and other short sellers and manipulated in their favor and
attacked the company by creating a fear and panic in the minds of investors
that other insurance companies will follow what Aetna did and qcor will lose
majority of its revenues. Coming back to the lawsuit, personally, I think
it will do no harm to the company since they are promoting their drug for
the indications that are fda approved. This is good buying opportunity at
this current level.
POINT: CITRON manipulated the wording to attack QCOR.
Tomorrow will be a good day!
【在 T*C 的大作中提到】![](/moin_static193/solenoid/img/up.png)
: It's still good entry point now. Will see 30 soon
if you compare Aetna policy statement in 2008 and 9-12 (recently updated)
there is no change in aetna policy at all. Yes, they might make it more
difficult to approve prior auth. but they are no denying acthar therapy
after steroid therapy fails. The updated policy on 9-14-12 states " This CPB
is revised to state that repository corticotropin is considered not
medically necessary for corticosteroid-responsive conditions because it has
not been proven to be more effective than corticosteroids for these
indications". Now, the keyword here is "corticosteroid-respon... conditions"
which implies acthar gel will not be reimbursed for patients who are
responsive to steroid therapy. However, no where it says it will not
reimburse for patients who failed steroid therapy. This is the language used
by citron and other short sellers and manipulated in their favor and
attacked the company by creating a fear and panic in the minds of investors
that other insurance companies will follow what Aetna did and qcor will lose
majority of its revenues. Coming back to the lawsuit, personally, I think
it will do no harm to the company since they are promoting their drug for
the indications that are fda approved. This is good buying opportunity at
this current level.
POINT: CITRON manipulated the wording to attack QCOR.
Tomorrow will be a good day!
【在 T*C 的大作中提到】
![](/moin_static193/solenoid/img/up.png)
: It's still good entry point now. Will see 30 soon
相关阅读
今日wootOlympus E-450怎么样?发一个 sierratradingpost 的code,谁要谁拿iphone 4太爽了,第二集,sorry, 加几个图片 (转载)为啥negative film扫描出来颗粒这么重?[FS]全新5D2,无UPC北京的H1签证现在约到哪天了?90多ebuck要到期了iPhone4 的免费套套,选哪一个?现在万佛版俨然已经变成shopping版了......有没有结合kindle和ipad的电子书?虚心请教:为啥要戴这个套全新35L现在最便宜多少钱一直想不通一个问题rolleiflex warm?夏日解暑的deal, 本版分享, 请不要外传...请推荐能照和录远距离表演的相机或CAMCORDER万佛帮看看这个粟米克隆35mm怎么样终于被解放了! 拍娃革命机才是王道背照式CMOS 33mm f/2.4